West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$256.64 USD
-1.71 (-0.66%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $256.67 +0.03 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth D Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
For West Pharmaceutical Services, Inc., the company has a dividend yield of 0.33% compared to the Medical - Dental Supplies industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
WST 256.64 -1.71(-0.66%)
Will WST be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for WST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WST
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care
CAH Strengthens Distribution With New Consumer Health Logistics Hub
WST: What are Zacks experts saying now?
Zacks Private Portfolio Services
GEHC Expands Women's Health Portfolio With AI-Enabled Voluson
ISRG Stock Dips Despite Introducing Real-Time Insights on da Vinci 5
GEHC Eyes icometrix Buyout to Strengthen Neurology Imaging Portfolio
Other News for WST
WST rises 0.32% on September 16, leaving the technical picture intact
Optimistic Long-Term Growth Outlook for Wingstop Amid Strategic Initiatives and Expansion Plans
Is WST consolidating before a move? NR7 shows up after gaining 1.59%
Rothschild & Co Initiates Coverage on WST with a 'Buy' Rating | WST Stock News
West Pharmaceutical Services (WST) Has a New Rating from Redburn Atlantic